Wick, Michael J.
South Texas Accelerated Research Therapeutics
2 papers on CoChatORCID 0000-0001-5683-8687
Most cited papers
- Verified
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Shimizu, T., Tolcher, A. W., Papadopoulos, K. P., Beeram, M., Rasco, D. W., Smith, L. S., Gunn, S., Smetzer, L., Mays, T. A., Kaiser, B., et al. (2012) · Clinical Cancer Research
PI3K/AKT/mTOR signaling in cancerMelanoma and MAPK Pathways
Cited by 431
- Verified
Hyperactivation of TORC1 drives resistance to the pan-HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers
Sudhan, D. R., Guerrero-Zotano, A., Won, H., González Ericsson, P., Servetto, A., Huerta-Rosario, M., Ye, D., Lee, K.-M., Formisano, L., Guo, Y., et al. (2020) · Cancer Cell
PI3K/AKT/mTOR signaling in cancerHER2/EGFR in Cancer Research
Cited by 49
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free